Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Inventory (2016 - 2025)

Bioceres Crop Solutions' Inventory history spans 9 years, with the latest figure at $87.6 million for Q2 2025.

  • For Q2 2025, Inventory fell 30.43% year-over-year to $87.6 million; the TTM value through Jun 2025 reached $87.6 million, down 30.43%, while the annual FY2025 figure was $87.6 million, 30.43% down from the prior year.
  • Inventory for Q2 2025 was $87.6 million at Bioceres Crop Solutions, down from $125.9 million in the prior quarter.
  • Across five years, Inventory topped out at $125.9 million in Q2 2024 and bottomed at $8.6 million in Q4 2021.
  • The 5-year median for Inventory is $83.2 million (2022), against an average of $75.3 million.
  • The largest annual shift saw Inventory soared 101.67% in 2022 before it plummeted 30.43% in 2025.
  • A 5-year view of Inventory shows it stood at $8.6 million in 2021, then soared by 812.31% to $78.8 million in 2022, then soared by 42.19% to $112.0 million in 2023, then grew by 12.45% to $125.9 million in 2024, then tumbled by 30.43% to $87.6 million in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Inventory are $87.6 million (Q2 2025), $125.9 million (Q2 2024), and $112.0 million (Q2 2023).